how many people are on glp 1 drugs Poll: in 8 Adults Say They've Taken a GLP-1 Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease GLP-1 drugs linked to lower

Findings: On the 10 GLP-1 receptor agonists included in the cohort, drug manufacturers listed with the FDA a median of 19.5 patents (interquartile range [IQR]: 9.0-25.8) per product, including a median of 17 patents (IRQ: 8.3-22.8) filed before FDA approval and 1.5 (IQR: 0-2.8) filed after FDA approval

Beyond weight loss: a case study and narrative review of the potential role of glucagon-like peptide-1 receptor agonists for the treatment of idiopathic intracranial hypertension

doi: 10.1016/j.jacc.2008.10.033 [DOI] [PubMed] [Google Scholar] 140

Notably, based on the results from part 1 of the ESSENCE trial, on 15 August 2025, the FDA approved semaglutide 2.4 mg for the treatment of adults with MASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis)

Understanding IIH IIH is thought to involve abnormal CSF pressure regulation, venous outflow, and metabolic or hormonal factors

For some, side effects are severeespecially at the higher doses needed to achieve their health goals